Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells
Article in Toxicology in Vitro (June 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Toxicology in Vitro (June 2024)
Article in Life Sciences (May 2024)
Article in Natural Product Communications (April 2024)